- Home
- USIO vs DTIL Comparison
USIO vs DTIL Comparison
Compare USIO & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USIO
- DTIL
- Stock Information
- Founded
- USIO 1998
- DTIL 2006
- Country
- USIO United States
- DTIL United States
- Employees
- USIO N/A
- DTIL N/A
- Industry
- USIO Investment Bankers/Brokers/Service
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- USIO Finance
- DTIL Health Care
- Exchange
- USIO Nasdaq
- DTIL Nasdaq
- Market Cap
- USIO 37.8M
- DTIL 44.1M
- IPO Year
- USIO N/A
- DTIL 2019
- Fundamental
- Price
- USIO $1.61
- DTIL $4.96
- Analyst Decision
- USIO Strong Buy
- DTIL Strong Buy
- Analyst Count
- USIO 2
- DTIL 3
- Target Price
- USIO $5.00
- DTIL $37.67
- AVG Volume (30 Days)
- USIO 795.8K
- DTIL 1.2M
- Earning Date
- USIO 03-26-2025
- DTIL 03-26-2025
- Dividend Yield
- USIO N/A
- DTIL N/A
- EPS Growth
- USIO N/A
- DTIL N/A
- EPS
- USIO 0.13
- DTIL 1.45
- Revenue
- USIO $81,027,258.00
- DTIL $75,096,000.00
- Revenue This Year
- USIO $2.94
- DTIL $51.35
- Revenue Next Year
- USIO $14.59
- DTIL N/A
- P/E Ratio
- USIO $12.37
- DTIL $3.43
- Revenue Growth
- USIO N/A
- DTIL 43.62
- 52 Week Low
- USIO $1.24
- DTIL $3.61
- 52 Week High
- USIO $2.92
- DTIL $19.43
- Technical
- Relative Strength Index (RSI)
- USIO 42.91
- DTIL 43.61
- Support Level
- USIO $1.77
- DTIL $4.83
- Resistance Level
- USIO $1.96
- DTIL $5.41
- Average True Range (ATR)
- USIO 0.21
- DTIL 0.41
- MACD
- USIO -0.10
- DTIL 0.04
- Stochastic Oscillator
- USIO 3.33
- DTIL 13.08
About USIO Usio Inc.
Usio Inc is a United States-based company that provides integrated electronic payment services, including credit and debit card-based processing services and transaction processing via the Automated Clearing House, or ACH network to billers and retailers. The Company also has an additional wholly-owned subsidiary, which is the entity for the Output Solutions operations.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.